Company · founded 1961
Advanced Bioscience Laboratories (United States)
Rockville, United States · ablinc.com
- Citations, last 5 years
- 130
- Works, last 5 years
- 11
- h-index
- 96
- Scientists listed
- 4
- Grants since 2016
- 173
Grants received
2017–2022 · contract · N01
Transcriptomics of RhCMV/SIV Vector-Vaccinated Macaques
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS
Glen Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
TASK X21: ADMINISTRATIVE - MANUFACTURING AND CHARACTERIZATION SERVICES FOR VACCINES AND OTHER BIOLOGICS
Ziv Sandalon · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy R Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
STATISTICAL SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2025 · contract · N01
Production of a Chimpanzee Adenovirus HIV-1 Vaccine
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
Advancing Development of Multipurpose Prevention Technologies (MPTs)
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2023 · contract · N01
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2023 · contract · N01
PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2028 · contract · N01
Production of a Chimpanzee Adenovirus HIV-1 Vaccine
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
Statistical Support for HIV Non-vaccine Biomedical Prevention Product Development
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
Task X20:Master Cell Banks
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT: TASK F
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
SIMIAN VACCINE EVALUATION UNITS: Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
QUALITY ASSURANCE/ QUALITY CONTROL (QA/QC)
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2023 · contract · N01
PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
Phillip Ishikawa · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION FEASIBILITY STUDY
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2022 · contract · N01
NIAID Preclinical Development Support - Production of GEO-D02 DNA Drug Product
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2023 · contract · N01
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2016–2028 · contract · N01
Production of a Chimpanzee Adenovirus HIV-1 Vaccine
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2015–2022 · contract · N01
Production of eCD4-IG protein
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2015–2022 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2015–2022 · contract · N01
Production of eCD4-IG protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
Nancy Lin · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
Nancy Lin · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health